Cargando…

A novel deep learning prognostic system improves survival predictions for stage III non‐small cell lung cancer

BACKGROUND: Accurate prognostic prediction plays a crucial role in the clinical setting. However, the TNM staging system fails to provide satisfactory individual survival prediction for stage III non‐small cell lung cancer (NSCLC). The performance of the deep learning network for survival prediction...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Linlin, Fan, Xinyu, Qin, Wenru, Xu, Yiyue, Zou, Bing, Fan, Bingjie, Wang, Shijiang, Dong, Taotao, Wang, Linlin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678103/ https://www.ncbi.nlm.nih.gov/pubmed/35491970 http://dx.doi.org/10.1002/cam4.4782

Ejemplares similares

Prophylactic cranial irradiation-related lymphopenia affects survival in patients with limited-stage small cell lung cancer
por: Fan, Xinyu, et al.
Publicado: (2023)

Transformation from Small Cell to Squamous Cell Carcinoma in a Thymic Carcinoma Patient with a Durable Response to Anlotinib: A Case Report
por: Qin, Wenru, et al.
Publicado: (2022)

Genome-wide DNA methylation signature predict clinical benefit of bevacizumab in non-small cell lung cancer
por: Li, Butuo, et al.
Publicado: (2022)

Integrating Clinical Data and Attentional CT Imaging Features for Esophageal Fistula Prediction in Esophageal Cancer
por: Xu, Yiyue, et al.
Publicado: (2021)

Comparison of the Incidence Rate of Radiation Pneumonitis Observed in Patients with Advanced Lung Adenocarcinoma Treated with Simultaneous Thoracic Radiotherapy and 1G/2G/3G EGFR-TKIs
por: Mu, Fengchun, et al.
Publicado: (2023)

Association between immune-related adverse events and the efficacy of PD-1 inhibitors in advanced esophageal cancer
por: Qin, Wenru, et al.
Publicado: (2022)

Multiple Immune Features-Based Signature for Predicting Recurrence and Survival of Inoperable LA-NSCLC Patients
por: Guo, Meiying, et al.
Publicado: (2020)

Three models that predict the efficacy of immunotherapy in Chinese patients with advanced non‐small cell lung cancer
por: Zhao, Qian, et al.
Publicado: (2021)

The Kinetic Changes of Systemic Inflammatory Factors during Bevacizumab Treatment and Its Prognostic Role in Advanced Non-small Cell Lung Cancer Patients
por: Li, Butuo, et al.
Publicado: (2019)

NcRNAs-mediated P2RX1 expression correlates with clinical outcomes and immune infiltration in patients with breast invasive carcinoma
por: Xu, Yiyue, et al.
Publicado: (2022)

XPO1-mutant NSCLC without STK11/KEAP1 mutations may predict better survival to immunotherapy
por: Li, Xuanzong, et al.
Publicado: (2021)

Integrated multi-dimensional deep neural network model improves prognosis prediction of advanced NSCLC patients receiving bevacizumab
por: Li, Butuo, et al.
Publicado: (2023)

Safety and Efficacy of Concurrent or Sequential Radiotherapy Plus (PD-1) Inhibitors in Oligometastatic Esophageal Cancer
por: Duan, Yanan, et al.
Publicado: (2023)

Delineating the pattern of treatment for elderly locally advanced NSCLC and predicting outcomes by a validated model: A SEER based analysis
por: Guo, Meiying, et al.
Publicado: (2019)

Development of a Novel Deep Learning-Based Prediction Model for the Prognosis of Operable Cervical Cancer
por: Dong, Taotao, et al.
Publicado: (2022)

Prognostic Value of a Nomogram Based on the Dynamic Albumin-to-Alkaline Phosphatase Ratio for Patients with Extensive-Stage Small-Cell Lung Cancer
por: Li, Butuo, et al.
Publicado: (2020)

Total nodule number as an independent prognostic factor in resected stage III non-small cell lung cancer: a deep learning-powered study
por: Chen, Xiuyuan, et al.
Publicado: (2022)

Development and validation of a risk prediction model for radiotherapy-related esophageal fistula in esophageal cancer
por: Xu, Yiyue, et al.
Publicado: (2019)

Construction of a B cell-related gene pairs signature for predicting prognosis and immunotherapeutic response in non-small cell lung cancer
por: Li, Xuanzong, et al.
Publicado: (2022)

IL2RA is a prognostic indicator and correlated with immune characteristics of pancreatic ductal adenocarcinoma
por: Fan, Liwen, et al.
Publicado: (2022)

Construction of subtype-specific prognostic gene signatures for early-stage non-small cell lung cancer using meta feature selection methods
por: Liu, Chunshui, et al.
Publicado: (2019)

Prognostic Factors Influencing Survival in Stage II and Stage III Colorectal Cancer Patients
por: Alkader, Mohammad S, et al.
Publicado: (2023)

Evaluation of factors associated with platinum-sensitivity status and survival in limited-stage small cell lung cancer patients treated with chemoradiotherapy
por: Wen, Qiang, et al.
Publicado: (2017)

The IGCA staging system is more accurate than AJCC7 system in stratifying survival of patients with gastric cancer in stage III
por: Shu, Ping, et al.
Publicado: (2017)

Prognostic evaluation of esophageal cancer patients with stages I-III
por: Qiu, Meng-jun, et al.
Publicado: (2020)

Improving the efficacy of combined radiotherapy and immunotherapy: focusing on the effects of radiosensitivity
por: Gao, Zhiru, et al.
Publicado: (2023)

Development and Validation of a Deep Learning Radiomics Model Predicting Lymph Node Status in Operable Cervical Cancer
por: Dong, Taotao, et al.
Publicado: (2020)

Prognostic effect of excessive chemotherapy cycles for stage II and III gastric cancer patients after D2 + gastrectomy
por: Li, Yi-Fan, et al.
Publicado: (2023)

Prognostic Factors in Stage III Non-Small-Cell Lung Cancer Patients
por: Urvay, Semiha Elmaci, et al.
Publicado: (2016)

Neurological paraneoplastic syndrome caused by small cell lung cancer: a case report
por: Yan, Wenxing, et al.
Publicado: (2020)

A deep learning quantified stroma-immune score to predict survival of patients with stage II–III colorectal cancer
por: Xu, Zeyan, et al.
Publicado: (2021)

Local ablative therapy with or without chemotherapy for non-small-cell lung cancer patients with postoperative oligometastases
por: Shang, Shuheng, et al.
Publicado: (2018)

A nomogram for the prediction of overall survival in patients with stage II and III non-small cell lung cancer using a population-based study
por: Liao, Yi, et al.
Publicado: (2019)

Prognostic Factors for Post-Recurrence Survival in Stage II and III Colorectal Carcinoma Patients
por: Nikolic, Neda, et al.
Publicado: (2021)

Toxicity Profile of Combining PD-1/PD-L1 Inhibitors and Thoracic Radiotherapy in Non-Small Cell Lung Cancer: A Systematic Review
por: Li, Butuo, et al.
Publicado: (2021)

Weighted gene expression profiles identify diagnostic and prognostic genes for lung adenocarcinoma and squamous cell carcinoma
por: Wu, Xing, et al.
Publicado: (2019)

Development of Autophagy Signature-Based Prognostic Nomogram for Refined Glioma Survival Prognostication
por: Fan, Yuxiang, et al.
Publicado: (2020)

Severe Pulmonary Toxicity With Concurrent Anlotinib and Chemoradiotherapy in Stage III NSCLC: The ALTER-L042 Phase 1 Clinical Trial
por: Zhu, Hui, et al.
Publicado: (2022)

A Prognostic Nomogram and Heat Map to Predict Survival in Stage II/III Gastric Cancer Patients After Curative Gastrectomy Followed by Adjuvant Chemotherapy
por: Shi, Litong, et al.
Publicado: (2022)

Cyclophilin A contributes to shikonin-induced glioma cell necroptosis and promotion of chromatinolysis
por: Wang, Xinyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jn3dkvq9ig0d94e1bs8252fnjb